Dr. Elwood V. Jensen

Timeline: 

January 13, 1920 – December 16, 2012

Place of study: 

Wittenberg University, Ohio

University of Chicago, Chicago

Contribution to breast cancer research: 

  • Dr. Jensen studied steroid hormones and isolated estrogen receptors, discovering their importance in breast cancer.
  • His research demonstrated that nearly 75% of all breast cancers express ERα, and that women showing significant ERα levels can receive nontoxic treatments.
  • His contribution revolutionized the field of breast cancer diagnosis and treatment.
  • Dr. Jensen also developed a 80% accurate method for predicting a breast cancer patient’s response to hormone therapy, which was a great achievement at that time.
  • Jensen laboratory generated the first polyclonal and monoclonal antibodies to the estrogen receptor.

Memberships:

The Endocrine Society, President (1980)

Ludwig Institute for Cancer Research, Director (1983-87)

Board of Scientific Counselors of the National Cancer Institute

National Advisory Child Health and Human Development Council

NCI-INSERM Committee on Hormonal Regulation and Cancer

Awards: 

Charles F. Kettering Prize (1980)

Fred Conrad Koch Award (1984)

Dorothy P. Landon Prize (2002)

Albert Lasker Award for Basic Medical Research (2004)

Fun fact:

Dr. Elwood had a favourite hobby of creating limericks, often on the spot!


REFERENCES:

  1. Greene GL. In Memoriam: Elwood Jensen (1920–2012) Mol Endocrinol. 2013 Oct;27(10):1589–1591.
  2. Elwood V. Jensen. Available from: https://en.m.wikipedia.org/wiki/Elwood_V._Jensen. Accessed on 08 October 2020.
Leave a Reply

Leave a Reply

Your email address will not be published. Required fields are marked *